CardieX Limited (ASX:CDX)
CardieX Limited (ASX:CDX) is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders.
The company’s ATCOR division is the world leader in medical devices for measuring arterial stiffness and central blood pressure waveforms based on its unique FDA-cleared and patented SphygmoCor® technology.
Under the ATCOR·X brand, the company also develops and licenses its Arty™ platform consisting of physiological and health analytics for wearable devices.
The company’s digital platform, ArtyNet™, is a connected SaaS ecosystem providing physicians with a complete telehealth solution for remotely managing patients’ health (2021 launch).